Stock INO INOVIO PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Analyst Reco. Inovio Pharmaceuticals, Inc.

Equities

INO

US45773H4092

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-24 pm EDT 		5-day change 1st Jan Change
10.16 USD -2.03% Intraday chart for Inovio Pharmaceuticals, Inc. -8.22% +66.01%
Apr. 16 Powell Comments, Middle East Tensions in Focus as US Equity Futures Gain Pre-Bell MT
Apr. 16 Inovio Pharmaceuticals Shares Slump Pre-Bell After Pricing of $36 Million Offering of Common Stock, Warrants MT

Analyst Reco.

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Inovio Pharmaceuticals Shares Slump Pre-Bell After Pricing of $36 Million Offering of Common Stock, Warrants
MT
Oppenheimer Upgrades Inovio Pharmaceuticals to Outperform From Perform, $4 Price Target
MT
RBC Trims Price Target on Inovio Pharmaceuticals to $2 From $3, Maintains Sector Perform Rating, Speculative Risk Qualifier
MT
Maxim Downgraded Inovio Pharmaceuticals to Hold From Buy
MT
BofA Securities Downgrades Inovio Pharmaceuticals to Underperform From Neutral With $2 Price Target
MT
Maxim Lowers Price Target for Inovio Pharmaceuticals to $5 From $11, Maintains Buy Rating
MT
RBC Reinstates Inovio Pharmaceuticals at Sector Perform-Speculative Risk, Assigns $4 Price Target, Awaiting 'More Attractive' Entry Point, 'Clearer Path for Value Creation'
MT
Oppenheimer Downgrades Inovio Pharmaceuticals to Perform From Outperform, Removes $30 Price Target
MT
RBC Cuts Price Target on Inovio Pharmaceuticals to $5 From $6, Maintains Sector Perform-Speculative Risk Rating
MT
Maxim Group Adjusts Inovio Pharmaceuticals Price Target to $11 From $20, Maintains Buy Rating
MT
BofA Securities Upgrades Inovio Pharmaceuticals to Neutral From Underperform, Adjusts Price Target to $10 From $8
MT
Jefferies Assumes Inovio Pharmaceuticals at Hold, $6 Price Target
MT
INOVIO PHARMACEUTICALS : BofA Securities Downgrades Inovio Pharmaceuticals to Underperform From Neutral, Sets $8 Price Target
MT
INOVIO PHARMACEUTICALS : Jefferies Starts Inovio Pharmaceuticals at Hold With $9 Price Target
MT
INOVIO PHARMACEUTICALS : RBC Reduces Price Target on Inovio Pharmaceuticals to $7 From $8, Maintains Sector Perform, Speculative Risk
MT
INOVIO PHARMACEUTICALS : BofA Securities Initiates Coverage on Inovio Pharmaceuticals With Neutral Rating, $13 Price Target
MT
INOVIO PHARMACEUTICALS : Oppenheimer Starts Inovio Pharmaceuticals at Outperform With $35 Price Target
MT
INOVIO PHARMACEUTICALS : Roth Capital Downgrades Inovio Pharmaceuticals Back to Sell From Neutral; Price Target Remains $8
MT
INOVIO PHARMACEUTICALS : Roth Capital Upgrades Inovio Pharmaceuticals to Neutral From Sell; Price Target is $8
MT
INOVIO PHARMACEUTICALS : RBC Capital Adjusts Inovio Pharmaceuticals PT to $11 From $12, Maintains Sector Perform - Speculative Risk
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. INO Stock
  4. News Inovio Pharmaceuticals, Inc.
  5. Analyst Reco.